148 related articles for article (PubMed ID: 38806877)
1. The impact of expanded access programs for systemic anticancer therapy in an Irish cancer centre.
Cronin TK; Ronayne C; O'Donovan N; McGuinness E; Cooke K; Dennehy M; Dennehy C; Power DG; Cahill MR; Collins DC; Connolly RM; Bambury RM; Mykytiv V; Higgins MJ; Noonan SA; O'Reilly S
Ir J Med Sci; 2024 May; ():. PubMed ID: 38806877
[TBL] [Abstract][Full Text] [Related]
2. Expanded Access Programme: looking for a common definition.
Iudicello A; Alberghini L; Benini G; Mosconi P
Trials; 2016 Jan; 17():21. PubMed ID: 26758369
[TBL] [Abstract][Full Text] [Related]
3. Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case.
Tarantola A; Otto MH; Armeni P; Costa F; Malandrini F; Jommi C
J Pharm Policy Pract; 2023 May; 16(1):67. PubMed ID: 37198599
[TBL] [Abstract][Full Text] [Related]
4. Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study.
Kiefer P; Kirschner J; Pechmann A; Langer T
Orphanet J Rare Dis; 2020 Jul; 15(1):194. PubMed ID: 32727502
[TBL] [Abstract][Full Text] [Related]
5. The current state of understanding of oncology expanded access programs in Malaysia.
Yong FL; Tan WC
Med J Malaysia; 2024 Mar; 79(2):191-195. PubMed ID: 38553925
[TBL] [Abstract][Full Text] [Related]
6. Expanded access protocol (EAP) program for access to investigational products for amyotrophic lateral sclerosis (ALS).
Yerton M; Winter A; Gelevski D; Addy G; Kostov A; Lieberman C; Weber H; Doyle M; Kane G; Cohen C; Parikh N; Burke KM; Rohrer M; Stirrat T; Bruno M; Hochman A; Luppino S; Scalia J; D'Agostino D; Sinani E; Yu H; Drake K; Hagar J; Sherman AV; Babu S; Berry JD; Cudkowicz ME; Paganoni S
Muscle Nerve; 2023 Jun; 67(6):456-463. PubMed ID: 36929648
[TBL] [Abstract][Full Text] [Related]
7. Differences in time to patient access to innovative cancer medicines in six European countries.
Vancoppenolle JM; Franzen N; Koole SN; Retèl VP; van Harten WH
Int J Cancer; 2024 Mar; 154(5):886-894. PubMed ID: 37864395
[TBL] [Abstract][Full Text] [Related]
8. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
9. Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study.
Senefeld JW; Johnson PW; Kunze KL; Bloch EM; van Helmond N; Golafshar MA; Klassen SA; Klompas AM; Sexton MA; Diaz Soto JC; Grossman BJ; Tobian AAR; Goel R; Wiggins CC; Bruno KA; van Buskirk CM; Stubbs JR; Winters JL; Casadevall A; Paneth NS; Shaz BH; Petersen MM; Sachais BS; Buras MR; Wieczorek MA; Russoniello B; Dumont LJ; Baker SE; Vassallo RR; Shepherd JRA; Young PP; Verdun NC; Marks P; Haley NR; Rea RF; Katz L; Herasevich V; Waxman DA; Whelan ER; Bergman A; Clayburn AJ; Grabowski MK; Larson KF; Ripoll JG; Andersen KJ; Vogt MNP; Dennis JJ; Regimbal RJ; Bauer PR; Blair JE; Buchholtz ZA; Pletsch MC; Wright K; Greenshields JT; Joyner MJ; Wright RS; Carter RE; Fairweather D
PLoS Med; 2021 Dec; 18(12):e1003872. PubMed ID: 34928960
[TBL] [Abstract][Full Text] [Related]
10. Osimertinib for Previously Treated Patients With Advanced EGFR T790M Mutation-Positive NSCLC: Tolerability and Diagnostic Methods From an Expanded Access Program.
Santos ES; Kaplan B; Kirshner E; Croft EF; Sequist LV; Chau M; Munley J; Oxnard GR
Oncol Ther; 2018 Jun; 6(1):45-58. PubMed ID: 32700141
[TBL] [Abstract][Full Text] [Related]
11. Influence of State-Level Emergency Planning Policy Requirements on Secondary School Adoption.
Scarneo-Miller SE; Kerr ZY; Adams WM; Belval LN; Casa DJ
J Athl Train; 2020 Oct; 55(10):1062-1069. PubMed ID: 32818958
[TBL] [Abstract][Full Text] [Related]
12. The Evolution of Employee Assistance Programs to Best Support Healthcare Organizations.
Couser GP; Nation JL; Apker DP; Connaughty SM; Hyde MA
J Healthc Manag; 2023 Nov-Dec 01; 68(6):404-419. PubMed ID: 37944172
[TBL] [Abstract][Full Text] [Related]
13. Emergency Action Planning in Secondary School Athletics: A Comprehensive Evaluation of Current Adoption of Best Practice Standards.
Scarneo SE; DiStefano LJ; Stearns RL; Register-Mihalik JK; Denegar CR; Casa DJ
J Athl Train; 2019 Jan; 54(1):99-105. PubMed ID: 30676786
[TBL] [Abstract][Full Text] [Related]
14. Multicenter expanded access program for access to investigational products for amyotrophic lateral sclerosis.
Neel DV; Baselga-Garriga C; Benson M; Keegan M; Chase M; D'Agostino D; Drake K; Hagar JL; Hasenoehrl MG; Kulesa-Kelley J; Leite A; Mohapatra S; Portaro SM; Pothier LM; Rosenthal J; Sherman AV; Yu H; McCaffrey A; Ho D; Luppino S; Bedlack R; Heitzman D; Ajroud-Driss S; Katz J; Felice K; Whitaker C; Ladha S; Alameda G; Locatelli E; Qureshi IA; Hotchkin MT; Hayden MR; Cudkowicz ME; Babu S; Berry JD; Paganoni S
Muscle Nerve; 2024 Jun; ():. PubMed ID: 38842106
[TBL] [Abstract][Full Text] [Related]
15. Availability of Investigational Medicines Through the US Food and Drug Administration's Expanded Access and Compassionate Use Programs.
Puthumana J; Miller JE; Kim J; Ross JS
JAMA Netw Open; 2018 Jun; 1(2):e180283. PubMed ID: 30646072
[TBL] [Abstract][Full Text] [Related]
16. Exploring men's use of mental health support offered by an Australian Employee Assistance Program (EAP): perspectives from a focus-group study with males working in blue- and white-collar industries.
Matthews LR; Gerald J; Jessup GM
Int J Ment Health Syst; 2021 Aug; 15(1):68. PubMed ID: 34348756
[TBL] [Abstract][Full Text] [Related]
17. Real-world data from the Portuguese Nivolumab Expanded Access Program (EAP) in previously treated Non Small Cell Lung Cancer (NSCLC).
Figueiredo A; Almeida MA; Almodovar MT; Alves P; Araújo A; Araújo D; Barata F; Barradas L; Barroso A; Brito U; Camacho E; Canário D; Cardoso T; Chaves A; Costa L; Cunha J; Duarte J; Estevinho F; Felizardo M; Fernandes JP; Ferreira L; Ferreira L; Fidalgo P; Freitas C; Garrido P; Gil N; Hasmucrai D; Jesus E; Lopes JA; de Macedo JE; Meleiro A; Neveda R; Nogueira F; Pantorotto M; Parente B; Pego A; Rocha M; Roque J; Santos C; Saraiva J; Silva E; Silva S; Simões S; Soares M; Teixeira E; Timóteo T; Hespanhol V
Pulmonology; 2020; 26(1):10-17. PubMed ID: 31630986
[TBL] [Abstract][Full Text] [Related]
18. Nonnegative definite EAP and ODF estimation via a unified multi-shell HARDI reconstruction.
Cheng J; Jiang T; Deriche R
Med Image Comput Comput Assist Interv; 2012; 15(Pt 2):313-21. PubMed ID: 23286063
[TBL] [Abstract][Full Text] [Related]
19. Early access provision: Awareness, educational needs and opportunities to improve oncology patients' access to care.
Krendyukov A; Singhvi S; Green-Morrison Y; Zabransky M
Front Oncol; 2022; 12():714516. PubMed ID: 36387084
[TBL] [Abstract][Full Text] [Related]
20. Employee assistance programs: a workplace resource to address intimate partner violence.
Pollack KM; Austin W; Grisso JA
J Womens Health (Larchmt); 2010 Apr; 19(4):729-33. PubMed ID: 20210539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
